Other
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One
Biogen Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One increased by 11.6% to $900.80M in Q1 2026 compared to the prior quarter. Over 3 years (FY 2020 to FY 2025), Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One shows a downward trend with a -14.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026
How to read this metric
Higher values indicate a larger portion of the portfolio is liquid and available for reinvestment or cash needs in the short term.
Detailed definition
This represents the amortized cost of debt securities in the available-for-sale portfolio that are scheduled to mature w...
Peer comparison
Standard maturity bucket reporting for insurance investment portfolios.
Metric ID:
other_available_for_sale_securities_debt_maturities_with_72951fHistorical Data
12 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.31B | $1.41B | $1.54B | $2.00B | $2.15B | $1.24B | $1.48B | $2.15B | $3.47B | $97.60M | $807.20M | $900.80M |
| QoQ Change | — | +8.0% | +9.1% | +29.9% | +7.4% | -42.6% | +20.1% | +45.0% | +61.2% | -97.2% | +727.0% | +11.6% |
| YoY Change | — | — | — | — | +64.4% | -12.6% | -3.8% | +7.4% | +61.2% | — | — | — |
Range$97.60M – $3.47B
CAGR-12.7%
Avg YoY Growth+23.3%
Median YoY Growth+7.4%
Current Streak2 quarters growth
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One at Other Companies
Frequently Asked Questions
- What is Biogen's debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, year one?
- Biogen (BIIB) reported debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, year one of $900.80M in Q1 2026.
- What is the long-term trend for Biogen's debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, year one?
- Over 3 years (2020 to 2025), Biogen's debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, year one has grown at a -14.2% compound annual growth rate (CAGR), from $1.28B to $807.20M.
- What does debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, year one mean?
- The book value of debt investments that will reach their maturity date within the next twelve months.